Concepedia

Daniel Bergman

DB

Statistics

Publications

8

Citations

137

H-Index

8

Active since

2021

Affiliations

Johns Hopkins University(Current)

Sidney Kimmel Comprehensive Cancer Center

University of Michigan

Johns Hopkins Medicine

Indiana University Bloomington

Daniel Bergman is an author at Johns Hopkins University specializing in checkpoint inhibitor combinations, tumor progression, and immune checkpoint inhibitor therapy.

ORCID

Publications per year

2021–2025

8

Publications

8

Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories

Jeanette Johnson, Daniel Bergman, Heber L. Rocha et al. · Cell · 2025 · 42 citations · Full text

, , +17

A validated mathematical model of FGFR3‐mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer

Kamaldeen Okuneye, Daniel Bergman, Jeffrey Bloodworth et al. · Computational and Systems Oncology · 2021 · 17 citations · Full text

, , +17

PhysiCell Studio: a graphical tool to make agent-based modeling more accessible

Randy Heiland, Daniel Bergman, Blair Lyons et al. · Gigabyte · 2024 · 15 citations · Full text

, , +17

Digitize your Biology! Modeling multicellular systems through interpretable cell behavior

Jeanette Johnson, Genevieve Stein-O’Brien, M. Booth et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2023 · 14 citations · Full text

, , +13

Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms

Yixuan Wang, Daniel Bergman, Erica Trujillo et al. · Scientific Reports · 2023 · 14 citations · Full text

, , +17

1–5 of 8